Current challenges for biological treatment of pharmaceutical-based contaminants with oxidoreductase enzymes: immobilization processes, real aqueous matrices and hybrid techniques
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://hdl.handle.net/1822/80276 |
Resumo: | The worldwide access to pharmaceuticals and their continuous release into the environment have raised a serious global concern. Pharmaceuticals remain active even at low concentrations, therefore their occurrence in waterbodies may lead to successive deterioration of water quality with adverse impacts on the ecosystem and human health. To address this challenge, there is currently an evolving trend toward the search for effective methods to ensure efficient purification of both drinking water and wastewater. Biocatalytic transformation of pharmaceuticals using oxidoreductase enzymes, such as peroxidase and laccase, is a promising environmentally friendly solution for water treatment, where fungal species have been used as preferred producers due to their ligninolytic enzymatic systems. Enzyme-catalyzed degradation can transform micropollutants into more bioavailable or even innocuous products. Enzyme immobilization on a carrier generally increases its stability and catalytic performance, allowing its reuse, being a promising approach to ensure applicability to an industrial scale process. Moreover, coupling biocatalytic processes to other treatment technologies have been revealed to be an effective approach to achieve the complete removal of pharmaceuticals. This review updates the state-of-the-art of the application of oxidoreductases enzymes, namely laccase, to degrade pharmaceuticals from spiked water and real wastewater. Moreover, the advances concerning the techniques used for enzyme immobilization, the operation in bioreactors, the use of redox mediators, the application of hybrid techniques, as well as the discussion of transformation mechanisms and ending toxicity, are addressed. |
id |
RCAP_cc5ad83801f7132cc6bf680bf811ee24 |
---|---|
oai_identifier_str |
oai:repositorium.sdum.uminho.pt:1822/80276 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Current challenges for biological treatment of pharmaceutical-based contaminants with oxidoreductase enzymes: immobilization processes, real aqueous matrices and hybrid techniquesOxidoreductasesPharmaceuticalsEnzyme immobilizationBiodegradationWastewaterHybrid techniquesScience & TechnologyThe worldwide access to pharmaceuticals and their continuous release into the environment have raised a serious global concern. Pharmaceuticals remain active even at low concentrations, therefore their occurrence in waterbodies may lead to successive deterioration of water quality with adverse impacts on the ecosystem and human health. To address this challenge, there is currently an evolving trend toward the search for effective methods to ensure efficient purification of both drinking water and wastewater. Biocatalytic transformation of pharmaceuticals using oxidoreductase enzymes, such as peroxidase and laccase, is a promising environmentally friendly solution for water treatment, where fungal species have been used as preferred producers due to their ligninolytic enzymatic systems. Enzyme-catalyzed degradation can transform micropollutants into more bioavailable or even innocuous products. Enzyme immobilization on a carrier generally increases its stability and catalytic performance, allowing its reuse, being a promising approach to ensure applicability to an industrial scale process. Moreover, coupling biocatalytic processes to other treatment technologies have been revealed to be an effective approach to achieve the complete removal of pharmaceuticals. This review updates the state-of-the-art of the application of oxidoreductases enzymes, namely laccase, to degrade pharmaceuticals from spiked water and real wastewater. Moreover, the advances concerning the techniques used for enzyme immobilization, the operation in bioreactors, the use of redox mediators, the application of hybrid techniques, as well as the discussion of transformation mechanisms and ending toxicity, are addressed.This study was supported by the Portuguese Foundation for Science and Technology (FCT) under the scope of the strategic funding of UIDB/04469/2020 unit, and by LABBELS – Associate Laboratory in Biotechnology, Bioengineering and Microelectromechnaical Systems, LA/P/0029/2020. Helena Sá thanks FCT for funding her PhD grant (UI/BD/151239/2021).info:eu-repo/semantics/publishedVersionMultidisciplinary Digital Publishing Institute (MDPI)Universidade do MinhoSá, Helena Isabel OliveiraMichelin, MicheleTavares, T.Silva, Bruna Andreia Nogueira Airosa2022-10-152022-10-15T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/1822/80276engSá, Helena; Michelin, Michele; Tavares, Teresa; Silva, Bruna, Current challenges for biological treatment of pharmaceutical-based contaminants with oxidoreductase enzymes: immobilization processes, real aqueous matrices and hybrid techniques. Biomolecules, 12(10), 1489, 20222218-273X10.3390/biom12101489362916981489https://www.mdpi.com/journal/biomoleculesinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-21T12:41:10Zoai:repositorium.sdum.uminho.pt:1822/80276Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T19:38:05.519659Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Current challenges for biological treatment of pharmaceutical-based contaminants with oxidoreductase enzymes: immobilization processes, real aqueous matrices and hybrid techniques |
title |
Current challenges for biological treatment of pharmaceutical-based contaminants with oxidoreductase enzymes: immobilization processes, real aqueous matrices and hybrid techniques |
spellingShingle |
Current challenges for biological treatment of pharmaceutical-based contaminants with oxidoreductase enzymes: immobilization processes, real aqueous matrices and hybrid techniques Sá, Helena Isabel Oliveira Oxidoreductases Pharmaceuticals Enzyme immobilization Biodegradation Wastewater Hybrid techniques Science & Technology |
title_short |
Current challenges for biological treatment of pharmaceutical-based contaminants with oxidoreductase enzymes: immobilization processes, real aqueous matrices and hybrid techniques |
title_full |
Current challenges for biological treatment of pharmaceutical-based contaminants with oxidoreductase enzymes: immobilization processes, real aqueous matrices and hybrid techniques |
title_fullStr |
Current challenges for biological treatment of pharmaceutical-based contaminants with oxidoreductase enzymes: immobilization processes, real aqueous matrices and hybrid techniques |
title_full_unstemmed |
Current challenges for biological treatment of pharmaceutical-based contaminants with oxidoreductase enzymes: immobilization processes, real aqueous matrices and hybrid techniques |
title_sort |
Current challenges for biological treatment of pharmaceutical-based contaminants with oxidoreductase enzymes: immobilization processes, real aqueous matrices and hybrid techniques |
author |
Sá, Helena Isabel Oliveira |
author_facet |
Sá, Helena Isabel Oliveira Michelin, Michele Tavares, T. Silva, Bruna Andreia Nogueira Airosa |
author_role |
author |
author2 |
Michelin, Michele Tavares, T. Silva, Bruna Andreia Nogueira Airosa |
author2_role |
author author author |
dc.contributor.none.fl_str_mv |
Universidade do Minho |
dc.contributor.author.fl_str_mv |
Sá, Helena Isabel Oliveira Michelin, Michele Tavares, T. Silva, Bruna Andreia Nogueira Airosa |
dc.subject.por.fl_str_mv |
Oxidoreductases Pharmaceuticals Enzyme immobilization Biodegradation Wastewater Hybrid techniques Science & Technology |
topic |
Oxidoreductases Pharmaceuticals Enzyme immobilization Biodegradation Wastewater Hybrid techniques Science & Technology |
description |
The worldwide access to pharmaceuticals and their continuous release into the environment have raised a serious global concern. Pharmaceuticals remain active even at low concentrations, therefore their occurrence in waterbodies may lead to successive deterioration of water quality with adverse impacts on the ecosystem and human health. To address this challenge, there is currently an evolving trend toward the search for effective methods to ensure efficient purification of both drinking water and wastewater. Biocatalytic transformation of pharmaceuticals using oxidoreductase enzymes, such as peroxidase and laccase, is a promising environmentally friendly solution for water treatment, where fungal species have been used as preferred producers due to their ligninolytic enzymatic systems. Enzyme-catalyzed degradation can transform micropollutants into more bioavailable or even innocuous products. Enzyme immobilization on a carrier generally increases its stability and catalytic performance, allowing its reuse, being a promising approach to ensure applicability to an industrial scale process. Moreover, coupling biocatalytic processes to other treatment technologies have been revealed to be an effective approach to achieve the complete removal of pharmaceuticals. This review updates the state-of-the-art of the application of oxidoreductases enzymes, namely laccase, to degrade pharmaceuticals from spiked water and real wastewater. Moreover, the advances concerning the techniques used for enzyme immobilization, the operation in bioreactors, the use of redox mediators, the application of hybrid techniques, as well as the discussion of transformation mechanisms and ending toxicity, are addressed. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-10-15 2022-10-15T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://hdl.handle.net/1822/80276 |
url |
https://hdl.handle.net/1822/80276 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Sá, Helena; Michelin, Michele; Tavares, Teresa; Silva, Bruna, Current challenges for biological treatment of pharmaceutical-based contaminants with oxidoreductase enzymes: immobilization processes, real aqueous matrices and hybrid techniques. Biomolecules, 12(10), 1489, 2022 2218-273X 10.3390/biom12101489 36291698 1489 https://www.mdpi.com/journal/biomolecules |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Multidisciplinary Digital Publishing Institute (MDPI) |
publisher.none.fl_str_mv |
Multidisciplinary Digital Publishing Institute (MDPI) |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799132917204516864 |